Drug-Receptor Interactions

A drug-receptor interaction is the reversible (or sometimes irreversible) binding of a drug molecule to a specific macromolecular target, most often a receptor protein, that initiates a pharmacological effect. The strength of this binding (affinity) and the fraction of targets occupied form the quantitative starting point for nearly all of pharmacodynamics.

Definition

A drug-receptor interaction is the binding of a drug (ligand) to a specific receptor or other macromolecular target, governed by the affinity between them, which determines receptor occupancy and is the initial event in producing a drug effect.

Scope

This topic covers the molecular basis of how drugs recognise and bind their targets, the major classes of drug targets, the law of mass action as applied to binding, and the concepts of affinity, occupancy, and binding equilibria. It treats the interaction as a reference concept and does not provide prescribing guidance.

Core questions

• What molecular targets do drugs bind, and how is recognition achieved?
• How does affinity determine the fraction of receptors occupied at a given concentration?
• How is binding (occupancy) related to the resulting effect?
• What is the difference between affinity and efficacy?

Key concepts

• Receptor and ligand
• Affinity and equilibrium dissociation constant
• Receptor occupancy
• Law of mass action
• Binding kinetics (association and dissociation)
• Drug target classes: receptors, enzymes, ion channels, transporters
• Selectivity and specificity
• Spare receptors (receptor reserve)

Key theories

Mass-action (occupancy) model of binding

Following Clark, the binding of a drug to its receptor is treated as a reversible bimolecular reaction obeying the law of mass action, so that fractional occupancy follows a hyperbolic (Langmuir-type) function of drug concentration characterised by an equilibrium dissociation constant.

Mechanisms

Drugs bind their targets through complementary, usually non-covalent, interactions (hydrogen bonds, ionic and hydrophobic contacts, van der Waals forces), and occasionally through covalent bonds that produce long-lasting effects. Binding is described by the law of mass action: at equilibrium, the fraction of receptors occupied is a saturable, hyperbolic function of drug concentration, summarised by the equilibrium dissociation constant. The four principal target classes are receptors (including the seven-transmembrane G-protein-coupled receptors), enzymes, ion channels, and transporters. Occupancy is necessary but not sufficient for effect: the conversion of occupancy into response depends on efficacy and on stimulus-response coupling, which is why operational models add a transducer function to relate binding to the observed effect.

Clinical relevance

Because affinity and selectivity determine which targets a drug engages, drug-receptor interaction concepts underlie how the actions and off-target effects of medicines are characterised. This entry is educational and describes binding principles at a conceptual level; it is not a basis for individual dosing or treatment decisions.

Evidence & guidelines

Standardised symbols and definitions for affinity constants, dissociation constants, and related binding terms are maintained by the IUPHAR Committee on Receptor Nomenclature and Drug Classification, providing the agreed vocabulary used to report drug-receptor interactions.

History

The idea that drugs act on specific 'receptive substances' was proposed by Langley and Ehrlich around the turn of the twentieth century. Clark gave the concept a quantitative form in the 1920s and 1930s by applying the law of mass action to drug binding, establishing the occupancy framework. Later identification and cloning of receptor proteins, including the seven-transmembrane G-protein-coupled receptors characterised by Lefkowitz and colleagues, turned the abstract receptor into a defined molecular target.

Debates

Does occupancy fully determine response?

Simple occupancy theory predicts effect tracks receptor occupancy, but the existence of spare receptors and tissue-dependent maximal responses showed that occupancy and effect are not identical, motivating efficacy and operational (transducer) models that separate binding from stimulus-response coupling.

Key figures

• Alfred Joseph Clark
• Paul Ehrlich
• John Newport Langley
• Robert Lefkowitz
• James Black

Seminal works

• clark-1933
• black-leff-1983
• pierce-2002

Frequently asked questions

What is affinity in a drug-receptor interaction?

Affinity is the tendency of a drug to bind its receptor; it is quantified by the equilibrium dissociation constant, where a lower value indicates tighter binding and therefore higher affinity.

Why can a drug occupy receptors without producing a maximal effect?

Because producing an effect also requires efficacy and efficient coupling of receptor activation to a downstream response; affinity governs binding, but the magnitude of the resulting effect depends on additional pharmacodynamic factors.